Renee Else Michels , Diana Maria Johanna Delnoij , Martinus Bertram de Graaff
{"title":"HTA between theory and practice: Exploring boundary work in broadening HTA For MedTech governance","authors":"Renee Else Michels , Diana Maria Johanna Delnoij , Martinus Bertram de Graaff","doi":"10.1016/j.hlpt.2025.101008","DOIUrl":null,"url":null,"abstract":"<div><h3>Objectives</h3><div>In this paper, we explore the social and political practices involved in broadening health technology assessment (HTA) for medical technology (MedTech) governance. We take as our case study the Dutch HTA Methodology 2021–2024 Program, which aimed to broaden HTA methodologies to the assessment of MedTech, and in so doing, broadened the stakeholders involved. Our research question is as follows: How do stakeholders involved in the program interpret HTA (methodologies) for MedTech, and how do they envision multi-stakeholder collaboration on HTA (methodologies)?</div></div><div><h3>Methods</h3><div>We conducted 19 semi-structured interviews with program participants, including committee members and grant applicants. We also spent 120 hours observing program meetings as non-participants and conducted document analysis.</div></div><div><h3>Results</h3><div>Using boundary work as a sensitizing concept, we describe how broadening the actors involved both introduced and exposed different interpretations of HTA and HTA methodologies for MedTech. We describe three ways in which participants envisioned (potential) integration of these interpretations, which we term collaboration hybrids. Each collaboration hybrid encapsulates a way of navigating across boundaries.</div></div><div><h3>Conclusions</h3><div>Our findings highlight that attempts to broaden HTA into a more prominent aspect of MedTech governance challenge the boundaries of what is understood as proper HTA. We argue that reflecting explicitly on these different interpretations, and the diverse ways to integrate them, increases the relevance of the HTA methodologies developed and the collaborations initiated in the governance of MedTech through HTA.</div></div>","PeriodicalId":48672,"journal":{"name":"Health Policy and Technology","volume":"14 3","pages":"Article 101008"},"PeriodicalIF":3.4000,"publicationDate":"2025-03-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Health Policy and Technology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S221188372500036X","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"HEALTH POLICY & SERVICES","Score":null,"Total":0}
引用次数: 0
Abstract
Objectives
In this paper, we explore the social and political practices involved in broadening health technology assessment (HTA) for medical technology (MedTech) governance. We take as our case study the Dutch HTA Methodology 2021–2024 Program, which aimed to broaden HTA methodologies to the assessment of MedTech, and in so doing, broadened the stakeholders involved. Our research question is as follows: How do stakeholders involved in the program interpret HTA (methodologies) for MedTech, and how do they envision multi-stakeholder collaboration on HTA (methodologies)?
Methods
We conducted 19 semi-structured interviews with program participants, including committee members and grant applicants. We also spent 120 hours observing program meetings as non-participants and conducted document analysis.
Results
Using boundary work as a sensitizing concept, we describe how broadening the actors involved both introduced and exposed different interpretations of HTA and HTA methodologies for MedTech. We describe three ways in which participants envisioned (potential) integration of these interpretations, which we term collaboration hybrids. Each collaboration hybrid encapsulates a way of navigating across boundaries.
Conclusions
Our findings highlight that attempts to broaden HTA into a more prominent aspect of MedTech governance challenge the boundaries of what is understood as proper HTA. We argue that reflecting explicitly on these different interpretations, and the diverse ways to integrate them, increases the relevance of the HTA methodologies developed and the collaborations initiated in the governance of MedTech through HTA.
期刊介绍:
Health Policy and Technology (HPT), is the official journal of the Fellowship of Postgraduate Medicine (FPM), a cross-disciplinary journal, which focuses on past, present and future health policy and the role of technology in clinical and non-clinical national and international health environments.
HPT provides a further excellent way for the FPM to continue to make important national and international contributions to development of policy and practice within medicine and related disciplines. The aim of HPT is to publish relevant, timely and accessible articles and commentaries to support policy-makers, health professionals, health technology providers, patient groups and academia interested in health policy and technology.
Topics covered by HPT will include:
- Health technology, including drug discovery, diagnostics, medicines, devices, therapeutic delivery and eHealth systems
- Cross-national comparisons on health policy using evidence-based approaches
- National studies on health policy to determine the outcomes of technology-driven initiatives
- Cross-border eHealth including health tourism
- The digital divide in mobility, access and affordability of healthcare
- Health technology assessment (HTA) methods and tools for evaluating the effectiveness of clinical and non-clinical health technologies
- Health and eHealth indicators and benchmarks (measure/metrics) for understanding the adoption and diffusion of health technologies
- Health and eHealth models and frameworks to support policy-makers and other stakeholders in decision-making
- Stakeholder engagement with health technologies (clinical and patient/citizen buy-in)
- Regulation and health economics